Latest Als News

Neurizon Therapeutics received FDA guidance on its IND application for NUZ-001, with a single request for additional animal exposure data but no safety concerns flagged. The company is actively addressing the FDA’s request while evaluating impacts on its ALS trial timeline.

Orora reports a 24.6% rise in underlying EBIT to $120.8 million for H1 FY25, driven by the Saverglass acquisition and portfolio simplification, while navigating operational challenges and market headwinds.

Solis Minerals has confirmed extensive copper porphyry mineralisation at its Cinto Project in Peru, revealing promising assay results and advancing towards drilling in late 2025.

Neurizon Therapeutics has been granted a pivotal US patent for its lead drug candidate NUZ-001, extending protection until 2039 and enhancing its commercial and clinical positioning in neurodegenerative disease treatment.

Alara Resources reports a marked increase in copper production at its Wash-hi-Majaza mine in Oman alongside encouraging early exploration results from the Block 8 concession, signaling potential growth in its copper-gold portfolio.

Site Group International edges closer to securing a pivotal Higher Training Institute license in Saudi Arabia, while reporting a robust 112% revenue surge and completing a $1 million capital raise to fuel expansion.

Metal Bank Limited reports significant progress across its Australian and MENA projects, including a strategic review of its Livingstone Gold Project and new exploration rights in Saudi Arabia and Jordan, supported by a fully subscribed $1.56 million entitlement offer.

Blaze Minerals secures a 60% stake in Gecko Minerals Uganda, completes initial drilling at Mityana, and raises $1.25 million to fuel exploration of critical metals in Uganda.

Control Bionics has delivered its strongest US sales quarter in years, nearing US$1 million in revenue, while broadening its market footprint with new commercial agreements and cost optimizations.

SRJ Technologies reported a remarkable 178% increase in Q4 FY24 cash receipts, driven by strong contract activity and strategic partnerships, including a key Middle East market entry. Despite some project delays, the company remains confident in its growth trajectory for FY25.

Advanced Health Intelligence Ltd has locked in a USD$4 million convertible note facility with UAE-based KOR Investments LLC, aiming to raise up to AUD$10 million to fuel its MENA expansion and reduce debt.

Alara Resources reports significant copper mineralisation discoveries in Oman’s Block 8, with initial assays revealing grades up to 4.46% Cu, setting the stage for intensified exploration alongside Power Metal Resources.